US Senate committee investigates weight-loss drug costs as NC negotiates with manufacturer
A U.S. Senate committee is investigating the prices that Novo Nordisk charges for its blockbuster medications, Ozempic and Wegovy. North Carolina officials, who canceled coverage of the drugs over costs, are trying to negotiate lower prices with the drug maker.
Dani Blum, New York Times